Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies. Stephens DM, Byrd JC. Blood 2021;138:1099-1109.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stephens DM, Byrd JC. Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies. Blood 2021;138:1099-1109.
PMID: 34320163